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Sterile inflammation triggered by endogenous factors
is thought to contribute to the pathogenesis of acute
and chronic inflammatory diseases. Here, we demon-
strate that apoptosis-deficient mutants spontane-
ously develop a necrosis-driven systemic immune
response in Drosophila and provide an in vivo model
for studying theorganismal response to sterile inflam-
mation. Metabolomic analysis of hemolymph from
apoptosis-deficient mutants revealed increased sar-
cosine and reduced S-adenosyl-methionine (SAM)
levels due to glycine N-methyltransferase (Gnmt)
upregulation. We showed that Gnmt was elevated in
response toToll activation inducedby the local necro-
sis of wing epidermal cells. Necrosis-driven inflam-
matory conditions induced dFoxO hyperactivation,
leading to an energy-wasting phenotype. Gnmt was
cell-autonomously upregulated by dFoxO in the fat
body as a possible rheostat for controlling energy
loss, which functioned during fasting as well as in-
flammatory conditions. We propose that the dFoxO-
Gnmt axis is essential for the maintenance of organ-
ismal SAM metabolism and energy homeostasis.
INTRODUCTION
Apoptosis is required for the proper removal of unneeded or
damaged cells (Fuchs and Steller, 2011; Miura, 2011). When
apoptosis is defective, the apoptosis-deficient cells either
survive aberrantly or die by nonapoptotic cell death such as
necrosis/necroptosis (Yuan and Kroemer, 2010; Kaczmarek
et al., 2013). Necrotic cell death induces noninfectious ‘‘sterile’’
inflammation via the release of damage-associated molecular
patterns (DAMPs). DAMP-mediated inflammation is involved
in the pathogenesis of various diseases, including cancer,
ischemia/reperfusion, neurodegeneration, atherosclerosis, and
systemic inflammatory response syndrome (Martin et al., 2012;
Rock et al., 2010; Zheng et al., 2011; Nagata et al., 2010; Griven-
nikov et al., 2010; Glass et al., 2010). Normally, tissue damagetriggers an inflammatory response that is required for tissue
repair; however, continuous or severe tissue damage can lead
to hazardous inflammation. Organisms may have various
responses, including an adaptive mechanism for the protection
against severe inflammation, but this area has not been thor-
oughly investigated. To study such responses to sterile inflam-
mation, we established a Drosophila model of a necrosis-driven
systemic immune response using darkmutant flies, which exhibit
defective wing apoptosis following eclosion.
Metabolism is tightly regulated by organisms under normal
physiological states but exhibits flexibility in response to altered
conditions. One of the most versatile metabolites, S-adenosyl-
methionine (SAM), is a methyl-group donor required for the
more than 200 known and putative methyltransferases encoded
in the human genome (Lu and Mato, 2012; Petrossian and
Clarke, 2011). In mammals, SAM is generated by methionine ad-
enosyltransferase/SAM synthetase from ATP and methionine,
and SAM levels are regulated primarily by glycine N-methyltrans-
ferase (Gnmt), which regulates SAM levels by consuming SAM to
produce sarcosine in the liver (Luka et al., 2009). Either chronic
depletion (Mat1a/) or chronic elevation (Gnmt/) of SAM
results in spontaneous hepatocellular carcinoma and impaired
liver regeneration (Martı´nez-Chantar et al., 2002, 2008; Chen
et al., 2004; Varela-Rey et al., 2009), indicating that regulation
of proper SAM levels is necessary for homeostasis. In yeast,
SAM levels regulate proliferation and autophagy through the
methylation of protein phosphatase 2A (PP2A) (Sutter et al.,
2013). SAM’s availability is also critical for lipogenesis in nema-
todes and HepG2 cells through the methylation of phosphoetha-
nolamine and phosphatidyl-ethanolamine, respectively (Walker
et al., 2011). Furthermore, a recent report indicates that the met-
formin-dependent lifespan increase in nematodes is mediated
by altered folate and methionine/SAM metabolism in the gut
microbiota (Cabreiro et al., 2013). These findings collectively
demonstrate SAM’s impact on cellular and organismal physi-
ology. However, little is known about the mechanisms regulating
the organismal SAM levels under physiological and pathological
states. For example, the induced expression of nicotinamide
N-methyltransferase (NNMT) in cancer cells was found to reduce
SAM levels, thereby affecting histone and PP2A methylation
(Ulanovskaya et al., 2013), yet themolecular mechanisms under-
lying NNMT induction remain to be elucidated. Administration ofCell Reports 7, 821–833, May 8, 2014 ª2014 The Authors 821
retinoic acid in rats induced hepatic Gnmt expression by un-
known mechanisms, resulting in reduced global DNA methyl-
ation (Ozias and Schalinske, 2003; Rowling et al., 2002). The
reductions in SAM levels were observed in the brain and
cerebrospinal fluid of Alzheimer’s disease patients (Morrison
et al., 1996; Linnebank et al., 2010), in the plasma of children
with autism (James et al., 2004), and in the liver after partial
hepatectomy (Huang et al., 1998) or in response to hepatic injury
induced by ethanol (Halsted and Medici, 2012; Kharbanda,
2013) or carbon tetrachloride (Varela-Moreiras et al., 1995).
SAM administration in these conditions impacts on the
pathological consequences, implying that altered SAM levels
are of medical importance. Nevertheless, molecular mecha-
nisms underlying the regulation of SAM levels in vivo are not
elucidated yet.
In this study, we revealed an energy-wasting phenotype in
Drosophila models for a necrosis-driven systemic immune
response. From the genetic studies with a combination to the
metabolome analysis, we demonstrated that a FOXO-mediated
system is activated that regulates SAM levels as a possible
protective mechanism against energy loss under inflammatory
conditions and starvation stress in vivo.
RESULTS
Defective Apoptosis of Wing Epidermal Cells Leads to
a Necrosis-Driven Systemic Immune Response
Apoptosis is primarily executed by an evolutionarily conserved
signaling process including caspases and their activator,
apoptotic protease activating factor-1 (Apaf-1) (Green, 2005).
In the hypomorphic Drosophila Apaf-1 (dark/dpf-1/HAC-1)
mutant darkcd4, apoptosis is impaired during development, but
a significant portion of the mutants survive to adulthood (Rodri-
guez et al., 1999). We noticed that the wings were gradually
melanized within 5 days after eclosion in almost all of the darkcd4
mutant flies examined (Figure 1A; Figure S1A). Drosophila wings
are initially folded but expand within an hour after eclosion, fol-
lowed by wing epidermal cell (WEC) apoptosis and elimination.
Previous reports indicated that an inhibition of WEC apoptosis
leads to incomplete cell elimination, resulting in the accumula-
tion of cell remnants inside the wings and in wing melanization
(Kimura et al., 2004; Link et al., 2007). Therefore, we assumed
that apoptosis-deficient WECs eventually die by necrosis, trig-
gering melanization. Indeed, we observed propidium iodide
(PI)-positive necrotic cells in the wings of day 5 darkmutant flies
(Figures 1B and S1B). We confirmed by Hoechst staining that
these PI-positive particles were DNA of necrotic cells, and we
also observed that some cells were still alive and were PI nega-
tive but Hoechst positive (Figures 1B and S1B). The wing mela-
nization was completely rescued by introducing one copy of the
genomic fragment containing dark (darkBAC/+) (Figure 1C). Wing
melanization was also observed when dark was knocked down
by overexpressing short hairpin RNA for dark (dark-sh) by WP-
Gal4, in which Gal4 was expressed in WECs (Figures 1C, S1A,
and S1C). The same phenotype was observed when dronc
was knocked down by WP-Gal4 or dark was knocked down by
another wing driver, BxMS1096-Gal4, further confirming that
WEC necrosis triggered wing melanization (Figure 1C).822 Cell Reports 7, 821–833, May 8, 2014 ª2014 The AuthorsNext, to investigate the global effects of WEC necrosis, we
performed a microarray analysis on dark mutant flies. Many im-
mune-related molecules, including antimicrobial peptides
(AMPs), were upregulated dramatically (Tables S1 and S2). We
hypothesized that the necrotic WECs triggered a severe inflam-
matory response. Notably, all of the flies with melanized wings
developed an elevated immune response, as indicated by quan-
titative RT-PCR (qRT-PCR) analysis of the AMPs that were found
to be highly elevated in the microarray analysis (Figures 1D and
S1D). We assumed that the DAMPs produced by necrotic WECs
gained access to the entire body through the circulating hemo-
lymph, because Drosophila has an open circulatory system. To
visualize which tissue(s) elicited the immune reaction, we
checked the expression pattern of GFP reporters for two antimi-
crobial peptides,Drosocin andDrosomycin. Most of the fat body
cells residing throughout the body were GFP positive, indicating
the presence of systemic immune response driven by local WEC
necrosis (Figures 1E–1G and S1E). These data collectively indi-
cated that either the apoptosis-deficient mutants or the flies
with specific-inhibition of WEC apoptosis could serve as an
in vivo model for analyzing the organismal responses to a necro-
sis-driven systemic immune response.
Metabolic Profiling of the dark Mutant
Various metabolic intermediates have been identified as the
missing links underlying biological processes that occur under
both healthy and disease states. Indeed, several metabolites
impact inflammation, including lipid mediators, azelaic acid
monoester, and gut-bacterial-derived uracil or deoxycholic
acid (von Moltke et al., 2012; Serhan et al., 2008; Matsubara
et al., 2012; Lee et al., 2013; Yoshimoto et al., 2013). To identify
the metabolite(s) and/or metabolic pathway(s) that could be
affected by a necrosis-driven systemic immune response, we
performed the metabolic profiling of the hemolymph, in which
metabolites related to organismal homeostasis should be
released. The direct analysis of metabolites in the hemolymph
of adult Drosophila is straightforward but challenging because
of its limited quantity. However, a recent development in metab-
olome analysis using capillary electrophoresis mass spectrom-
etry (CE-MS) (Soga et al., 2003) enabled our analysis of the
metabolic profiling of darkmutants. Among 90 metabolites iden-
tified, only three—gluconate, oxamate, and sarcosine—were
elevated more than 2-fold in flies with two different dark mutant
alleles compared to wild-type flies (Figure 2A; Table S3).
Although the metabolic enzymes for gluconate and oxamate
have not been identified in Drosophila, the metabolism of sarco-
sine is evolutionarily conserved between mammals and flies.
Therefore, we focused on the sarcosine elevation in the dark
mutant. We confirmed that sarcosine was elevated in flies with
several different darkmutant alleles by analyzing whole-body ho-
mogenates using ultra-high-performance liquid chromatography
with tandem mass spectrometry (UPLC-MS/MS) (Figure S2A).
Gnmt Is an Evolutionarily Conserved Regulator of SAM,
and Its Expression Is Induced by Necrotic WECs
Sarcosine is synthesized by glycine N-methyltransferase
(GNMT) andmetabolized to glycine by sarcosine dehydrogenase
(SARDH) in mammals, predominantly in the liver (Figure 2B). We
Figure 1. Defective Wing Epidermal Cell Apoptosis Triggers a Necrosis-Driven Systemic Immune Response
(A) Wing melanization in day 5 adult darkcd4 mutant flies.
(B) Propidium iodide (PI)-positive necrotic cells reside in the wings of day 5 adult darkcd4 flies. The scale bar represents 100 mm.
(C) Percentage of individuals with melanized wings (n > 50). The number of day 5 adult flies with wing melanization was counted, and individuals with melanized
wings per total flies are shown.WP and BxMS1096 are theGal4 drivers for wing epidermal cells. RNAi by short hairpin RNAs for dark or dronc (dark-sh or dronc-sh)
were used to block apoptosis.
(D) qRT-PCR analysis of antimicrobial peptides (Drosocin,Cecropin C, andAttacin A) in darkcd4 orWP>dark-sh flies.RNApol II served as the internal control. Data
are mean ± SEM (n = 5 for wild-type and darkcd4, n = 4 for WP-Gal4 lines). For this and the following graphs, *p < 0.05, **p < 0.01, and ***p < 0.0001 from the
biological replicates.
(E–G) Expression of GFP reporters for Drosocin (Dro) and Drosomycin (Drs) in day 5 adultWP>dark-sh flies. GFP expression was observed in the fat body cells.
The scale bar in (F) represents 100 mm, and the scale bar in (G) represents 50 mm.
See also Figure S1.identified the putative genes for each enzyme in the Drosophila
genome from the KEGG database (http://www.genome.jp/
kegg/pathway.html). CG6188 and CG6385 shared 57% and52% identity in amino acid sequence with human GNMT and
SARDH, respectively. We confirmed that these genes encoded
functional enzymes expressed mainly in the fat body, aCell Reports 7, 821–833, May 8, 2014 ª2014 The Authors 823
Figure 2. Defective Apoptosis Results in Sarcosine Elevation due to gnmt Upregulation
(A) CE-MS metabolome analysis of the hemolymph in two dark mutant alleles. Green and pink bars indicate darkk1 and darkk1/N5, respectively.
(B) Simplified diagram of sarcosine metabolism.
(C) Sarcosine levels in gnmt or sardh RNAi flies using the ubiquitous (da-Gal4) or fat body (r4-Gal4) drivers. For this and following all metabolite analyses by
UPLC-MS/MS, total metabolite levels from the same number of flies were compared. Data are mean ± SD (n = 4).
(D) qRT-PCR analysis of gnmt and sardh in dark mutants. RNA pol II served as the internal control. Data are mean ± SEM (n = 3; NS, not significant).
(E) Western blot analysis of Gnmt in dark or dronc RNAi flies (using da-Gal4) or in the darkcd4mutant. The dark RNAi used in this experiment was dark-IR; dark-sh
was not used here because it led to pupal lethality due to high RNAi efficiency.
See also Figure S2.counterpart of liver and white adipose tissue, given that the fat
body-specific and systemic knockdown of gnmt and sardh had
similar effects on the total sarcosine level (Figure 2C). To deter-
mine the molecular basis of the upregulated sarcosine levels in
darkmutants, we quantified the expression of the mRNA encod-
ing each enzyme and found that gnmt expression was upregu-
lated in the dark mutants, whereas sardh expression was
unchanged (Figures 2D, 2E, and S2B), findings that were also824 Cell Reports 7, 821–833, May 8, 2014 ª2014 The Authorsevident in the microarray analysis (Table S2). Furthermore, the
elevation of Gnmt in darkcd4 mutants was prevented by
introducing the one copy of genomic fragment containing the
wild-type dark allele, darkBAC (Figure S2C). We also observed
Gnmt elevation when either dark or the initiator caspase, dronc,
was knocked down using a ubiquitous Gal4 driver, confirming
that the inhibition of apoptosis induced Gnmt expression
(Figure 2E).
Figure 3. WEC Necrosis Induced Gnmt, a Regulator for SAM Levels and the Methylation Index
(A) Schematic view of the methionine cycle. Gly, glycine; Sar, sarcosine; SAM, S-adenosyl-methionine; SAH, S-adenosyl-homocysteine; Hcy, homocysteine;
Met, methionine.
(B) Schematic view of the gnmtMi mutant. Minos was inserted in the last exon of gnmt, disrupting intact Gnmt protein production.
(C) Methionine cycle metabolite levels in darkcd4 and gnmtMi mutants. Data are mean ± SD (n = 8).
(D) Methionine cycle metabolite levels in gnmt or sardh RNAi lines. Data are mean ± SD (n = 4).
(E) Methylation index of darkcd4 and gnmt or sardh RNAi lines. Data are mean ± SD (n = 8 for wild-type and darkcd4 flies, n = 4 for gnmt or sardh RNAi lines).
(F) Western blot analysis of Gnmt in dark RNAi flies. Drivers were r4-Gal4 (fat body), Pxn-Gal4 (hemocytes), NP1-Gal4 (ECs, enterocytes),WP-Gal4 (WECs), and
Elav-Gal4 (neurons).
(G) Methylation index of wing-specific dark or dronc RNAi lines. Data are mean ± SD (n = 4 for control, n = 6 for dark-sh and dronc-sh).
See also Figure S3.In mammals, Gnmt is coupled to themethionine cycle and reg-
ulates SAM levels (Figure 3A). Therefore, we analyzed the levels
ofmethionine-cyclemetabolites by UPLC-MS/MS in flies with fat
body-specific gnmt knockdown and gnmtMi mutants, which
contain a Minos transposon insertion in the gnmt coding region
(Figure 3B). As expected, neither Gnmt protein nor sarcosine
could be detected in gnmtMi mutants, confirming that this lineis a null mutant of gnmt and that Gnmt is inevitable for sarcosine
production (Figures 3C and S3A). The SAM levels in both gnmtMi
and gnmt knockdown flies were dramatically elevated (Figures
3C, 3D, and S3B), consistent with a previous report demon-
strating SAM elevation in Gnmt/ mice (Luka et al., 2006) and
indicating that Gnmt is an evolutionarily conserved regulator of
SAM.We also found that the levels of methionine were increasedCell Reports 7, 821–833, May 8, 2014 ª2014 The Authors 825
(Figures 3C, 3D, and S3B), as previously reported in Gnmt/
mice. In dark mutant flies, consistent with the elevated gnmt
expression, we observed a reduction in SAM and an increase
in S-adenosyl-homocysteine (SAH), the byproduct of methyl-
ation reactions (Figure 3C). When third-instar larvae were
analyzed, one-third of the SAM was found in the hemolymph,
and loss of gnmt in the fat body resulted in substantially elevated
SAM levels in the hemolymph (Figure S3C), indicating that Gnmt
in the fat body plays a central role in maintaining the systemic
SAM levels. Because SAM is required for methylation and SAH
inhibits methyltransferases, the SAM/SAH ratio has been pro-
posed to serve as a methylation index (MI), which indicates the
relative capacity for methylation (Figure S3D). In dark mutants,
the MI fell by approximately 50%, whereas it rose dramatically
in flies with reduced or loss of Gnmt expression (Figure 3E).
Because systemic dark or dronc RNAi resulted in Gnmt induc-
tion (Figure 2E), we next sought to determine the tissue that was
responsible for this phenotype. Using several different tissue-
specific Gal4 drivers, we found that Gnmt was strongly induced
when darkwas knocked down in the wing, but not in the fat body
(Figure 3F) tissue, suggesting that a wing-necrosis-driven sys-
temic immune response was the cause of Gnmt induction.
Indeed, Gnmt induction was observed in other flies with necrotic
WECs (Figure S3E). Consistent with Gnmt induction, reductions
in SAM and the MI were also observed in these flies (Figures 3G
and S3F). Therefore, we concluded that the necrosis-driven sys-
temic immune response is sufficient to induce the altered meta-
bolism of SAM.
ANecrosis-Driven Systemic Immune Response Triggers
an Energy-Wasting Phenotype via dFoxO
Hyperactivation
Our analysis of dark mutants revealed an unexpected connec-
tion between apoptosis deficiency-induced necrosis and SAM
metabolism. Next, we investigated the upstream activator of
Gnmt expression. The microarray analysis of dark mutants
described above also revealed elevated levels of several dFoxO
target genes, including Lipase3 (Lip3) and Thor/4E-BP, as well as
several antimicrobial peptides (Table S2) (Becker et al., 2010;
Wang et al., 2011). We confirmed by qRT-PCR analysis that
both Lip3 and Thor/4E-BP were elevated in dark mutants (Fig-
ures 4A and 4B). Similar results were observed in flies with
impaired WEC apoptosis (Figures 4A and S4A). We next evalu-
ated the tissue distribution of the dFoxO activation in
WP>dark-sh flies using Thor-lacZ as a reporter for dFoxO activa-
tion. Consistent with the immune-reaction-induced expression
of AMPs, lacZ expression was observed in the fat body of day
5 WP>dark-sh flies (Figure 4C), suggesting that dFoxO was
hyperactivated in the fat body. Consistent with the dFoxO-
mediated induction of lipase-3 expression, triacylglycerol (TAG)
levels were lower in the dark mutants, suggestive of an energy-
wasting phenotype, previously observed in Mycobacterium-
infected animals (Figure 4D) (Dionne et al., 2006). Indeed, these
flies were hypersusceptible to starvation stress (Figures 4E and
S4B), and this phenotype was partially rescued by introducing
a heterozygous dFoxO null allele (Figure 4E).
Two main immune regulators in Drosophila are the Toll and
IMD pathway, and the activation of Toll, but not IMD, in turn826 Cell Reports 7, 821–833, May 8, 2014 ª2014 The Authorsactivates dFoxO in the fat body (DiAngelo et al., 2009). A
15-fold induction of drosomycin (drs), a well-known target of
the Toll pathway, was also detected in the dark mutant micro-
array analysis (Table S2). In addition, strong GFP induction by
a drs-GFP reporter was observed in the fat body of the dark
mutant (Figures 1G and S1E). Altogether, these findings demon-
strated that the Toll pathway was activated in response to WEC
necrosis. Indeed, a reduction in spz, a Toll ligand, in darkcd4 flies
tended to suppress the Thor elevation and TAG reduction (Fig-
ures S4C–S4E). There was an approximately 70% increase in
the TAG amount in the dFoxO heterozygous mutant in darkcd4
(Figure S4C) and an approximately 30% increase in the wild-
type background (Figure S4D), indicating that the net rescue
effect of the attenuated dFoxO activation was about 40%. The
Spz heterozygous mutant showed an approximately 10%
decrease in the average TAG amount compared to wild-type
flies (Figure S4D) and an approximately 30% increase in the
darkcd4 background (Figure S4C), indicating an approximately
40% net rescue by introducing the heterozygous spz mutation,
similar to the dFoxOmutation. Both the spz and dFoxO heterozy-
gous mutants showed similar rescue phenotypes with regard to
dFoxO hyperactivation, which was tested by measuring the
Thor/4E-BP expression level by qRT-PCR (Figure S4E).
Therefore, we demonstrated that either the dFoxO or the spz
heterozygous mutation in darkcd4 could partially but significantly
rescue the reduced amount of TAG, confirming the involvement
of Toll signaling in the energy wasting mediated by dFoxO
hyperactivation.
A Necrosis-Driven Systemic Immune Response
Promotes Gnmt Upregulation via dFoxO
We demonstrated that necrotic WECs triggered an inflammatory
condition that led to energy wasting. Therefore, it is possible that
Gnmt was upregulated in response to necrosis-driven Toll acti-
vation and/or dFoxO activation. Gnmt elevation was suppressed
by dFoxO knockdown in fat bodies or by the introduction of het-
erozygotic dFoxO null or spz null alleles into the darkmutant (Fig-
ure 4F), suggesting that dFoxO activation is required for Gnmt
elevation. Furthermore, the loss of Gnmt protein expression
using fat body-specific gnmt-RNAi suggested that Gnmt was
induced in the fat body of dark mutants, consistent with the
dFoxO activation in this tissue (Figure 4F).
To determine whether Gnmt elevation is mediated by Toll and
dFoxO directly, we manipulated both the Toll pathway and
dFoxO activation without affecting the apoptosis machinery.
Toll activation achieved by overexpressing the active form of
spz resulted in Gnmt induction, and this induction was prevented
by dFoxO knockdown (Figure 5A), indicating that Toll activation
was sufficient for Gnmt elevation and that dFoxO activation was
necessary for the Toll-activation-induced Gnmt upregulation.
We then found that the SAM level and MI were both reduced in
flies that overexpressed active spz (Figure S5A). This phenotype
was partially but significantly rescued by suppressing dFoxO,
confirming the strong correlation between the SAM level and
Gnmt expression (Figure S5A).
Next, we investigated whether dFoxO activation was sufficient
for Gnmt elevation. We analyzed flies in which dFoxO was
overexpressed temporally in adults using the drug-inducible
Figure 4. The Necrosis-Driven Systemic Immune Response Elicits an Energy-Wasting Phenotype Mediated by dFoxO Activation in the Fat
Body
(A) qRT-PCR analysis of Lip3 in darkcd4 orWP>dark-sh flies. RNA pol II served as the internal control. Data are mean ± SEM (n = 5 for wild-type and darkcd4, n = 4
for WP-Gal4 lines).
(B) qRT-PCR analysis of Thor/4E-BP expression in either fed or 16-hr-starved flies.Rpl32 served as the internal control for this and all following experiments. Data
are mean ± SEM (n = 5 for wild-type, n = 7 for darkcd4).
(C) dFoxO activation in the fat body of WP>dark-sh flies as indicated by b-galactosidase immunostaining of the Thor-lacZ reporter product. The scale bar
represents 50 mm.
(D) Triacylglycerol (TAG) levels in fed or 16-hr-starved flies. Data are mean ± SD (n = 3).
(E) Starvation stress susceptibility (n = 60, *p < 0.0001 by the Kaplan-Meier log-rank test).
(F) dFoxO knockdown in the fat body (FB-Gal4 or r4-Gal4) or introduction of the spz or dFoxO heterozygous null mutation suppressed Gnmt elevation in darkcd4
mutants. Knockdown of Gnmt in the fat body completely abolished Gnmt protein expression, suggesting that Gnmt was elevated in the fat body of darkcd4 flies.
See also Figure S4.
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Figure 5. Toll Pathway Activation Leads to dFoxO-Mediated Gnmt Regulation in the Fat Body
(A) Gnmt induced by the active form of spz was suppressed by dFoxO knockdown in the fat body.
(B) qRT-PCR analysis ofGnmt or Thor in flies overexpressing dFoxO using the GeneSwitch inducible system, with or without the 2-day feeding of 250 mMRU486.
Data are mean ± SEM (n = 3).
(C) Elevated Gnmt protein levels in the inducible dFoxO-overexpressing flies.
(D) Gnmt is induced in dFoxO-overexpressing larval fat body clones. The scale bar represents 50 mm.Genotype: hs-flp122,UAS-mCD8-GFP;Actin>y>Gal4,UAS-
GFP/UAS-dFoxO.
(E) Gnmt expression in GFP-labeled clones expressing dFoxO and gnmt-sh, dFoxO-sh, or Pten. The scale bar represents 50 mm.
See also Figure S5.GeneSwitch (GS) system. Both Gnmt and starvation sensitivity
were increased in the presence of RU486, a GS inducer, indi-
cating that dFoxO overexpression was sufficient for inducing
both phenotypes (Figures 5B, 5C, and S5B). To determine
whether dFoxO regulates Gnmt expression cell autonomously,
we performed clonal analysis using larval fat body cells. GFP-
labeled, dFoxO-overexpressing clones expressed high Gnmt
levels, which were suppressed by gnmt-RNAi (Figures 5D and
5E). In contrast, dFoxO-RNAi clones expressed reduced levels
of Gnmt (Figure 5E), further indicating that Gnmt is regulated
by dFoxO in a cell-autonomous manner. Overexpression of
Pten, which induces dFoxO activation through the negative
regulation of phosphatidylinositol 3-kinase signaling, caused
strong Gnmt upregulation, indicating that dFoxO activation can
drive Gnmt expression (Figure 5E). In conclusion, these results828 Cell Reports 7, 821–833, May 8, 2014 ª2014 The Authorsindicate that dFoxO is necessary and sufficient for Gnmt eleva-
tion and that Toll pathway activation functions upstream of the
dFoxO-Gnmt axis in fat bodies. However, in contrast to the over-
expression of active Spz that stimulates the Toll pathway sys-
temically, Gnmt was not upregulated in Toll10b-overexpressing
clone cells, in which the Toll pathway was constitutively acti-
vated (Figures S5C and S5D). This observation suggests a
non-cell-autonomous mechanism for the Gnmt induction and
dFoxO hyperactivation by the activated Toll pathway.
Gnmt Induction as a Possible Protective Response to
Energy Wasting
Our findings showed that Gnmt was induced in response toWEC
necrosis via dFoxO activation. According to theDrosophila data-
base FlyBase (http://flybase.org/), Gnmt is predominantly
Figure 6. Gnmt Induction Is a Possible Pro-
tective Reaction against an Energy Loss
(A) Gnmt induction during starvation stress.
(B) Sarcosine, SAM, SAH, and methionine levels in
either fed or 16-hr-starved flies. Elevation of sar-
cosine and reduction of SAMwere observed. Data
are mean ± SD (n = 3)
(C) The methylation index was slightly reduced in
starved flies. Data are mean ± SD (n = 3)
(D) TAG levels in gnmtMi flies. Data are mean ±
SEM (n = 4).
(E and F) TAG levels in darkcd4 flies with loss or
knockdown of Gnmt in the fat body. Data are
mean ± SEM (n = 7 in E, n = 4 in F).
(G) Starvation stress susceptibility (n = 60, *p <
0.0001 by the Kaplan-Meier log-rank test).
See also Figure S6.expressed in the fat body, while SAM synthetase (sams) is ex-
pressed almost ubiquitously. Interestingly, the expression of
other enzymes in methionine-related metabolism, including
sams, were unchanged in the darkcd4 mutant, suggesting that
the dFoxO-dependent regulation of gnmt is distinctive (Fig-Cell Reports 7, 821ure S6A). dFoxO is known to upregulate
enzymes for catabolic programming,
such as lipases for TAG lipolysis during
fasting. Indeed, Gnmt elevation was also
observed in wild-type flies in response
to starvation stress (Figure 6A), while
both SAM and the MI were found to be
reduced (Figures 6B and 6C). The
dFoxO-dependent regulation of Gnmt
expression and, in turn, SAM levels
implies that Gnmt functions to modulate
the catabolic process. We wanted to
reveal whether the induction of Gnmt
and the reduction of SAM during fasting
or inflammation is hazardous or protec-
tive in regards to energy wasting. There-
fore, we further analyzed the energy-
storage-related phenotypes of gnmtMi
and gnmt knockdown flies. Loss of
Gnmt resulted in TAG reduction and hy-
persusceptibility to starvation stress (Fig-
ures 6D, 6G, and S6B), suggesting that
Gnmt functions to maintain the proper
levels of TAG. We hypothesized that
SAM levels affect phosphatidyletha-
nolamine N-methyltransferase (PEMT)-
dependent phosphatidylcholine synthe-
sis, which leads to SREBP-dependent
lipogenesis, as reported previously
(Walker et al., 2011). However, no puta-
tive Drosophila ortholog of Pemt was
found in the database, and dSREBP
target genes for lipogenesis were not
altered in either dark or gnmt mutants
(Figure S6C). In addition, the expressionof Thor appeared to be unchanged in gnmtmutants (Figure S6D),
suggesting that dFoxO activation is not a cause of the TAG
reduction in gnmt mutants.
Next, we tried to overexpress gnmt to see whether induced
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Figure 7. The Organismal Response to WEC Necrosis
A model of metabolic alterations triggered by defective WEC apoptosis. A
defect in apoptosis resulted in a necrosis-driven systemic immune response,
as indicated by the expression of antimicrobial peptides in the fat body, a
counterpart of liver and white adipose tissue. dFoxO is also activated in the
same tissue, which leads to an energy-wasting phenotype due to enhanced
lipolysis. Simultaneously, a SAM-regulating enzyme, Gnmt, is induced by
dFoxO cell autonomously and converts SAM to SAH as a possible adaptive
response against energy wasting.Unexpectedly, the overexpression of Flag-tagged gnmt in the fat
body did not show any effect on starvation sensitivity, despite
the increase in Gnmt protein levels in these flies (Figures S6E
and S6G). Only a slight reduction in SAM level and no difference
in the MI were observed (Figure S6F), although Flag-gnmt was
functional, because it could rescue the sarcosine and SAM levels
in gnmtmutant flies (Figures S6G and S6H). These findings sug-
gested that feedback mechanisms exist in flies for maintaining
the Gnmt activity.
Analogous to starvation stress, Gnmt upregulation in dark
mutant flies may also function as a protective response against
wasting triggered by the necrosis-driven systemic immune
response. Indeed, TAG reduction was enhanced by the loss or
knockdown of gnmt in the fat bodies of darkcd4 flies (Figures
6E and 6F). Consistent with this finding, starvation stress sensi-
tivity was also enhanced in darkcd4 gnmtMi double mutants (Fig-
ure 6G). Altogether, we conclude that Gnmt regulates SAM levels
under inflammatory or fasting conditions and may serve as a
rheostat for the dFoxO-dependent lipolytic program, thus func-
tioning to maintain proper energy levels (Figure 7).
DISCUSSION
WECs undergo apoptosis en masse shortly after eclosion.
Apoptosis-deficient WECs give rise to large numbers of live cells830 Cell Reports 7, 821–833, May 8, 2014 ª2014 The Authorsthat eventually die by necrosis. TheWEC apoptosis in flies abso-
lutely requires dark, in contrast to mammals, which possess
‘‘bypass’’ mechanisms that allow apaf-1-deficient cells to acti-
vate caspase (Nagasaka et al., 2010). Thus, in flies, the inhibition
of WEC apoptosis is sufficient to induce a necrosis-driven sys-
temic immune response. We demonstrated that WEC necrosis
triggers Toll activation. The Toll pathway was originally identified
in Drosophila, and subsequent studies in mammals identified
Toll-like receptors as central players in innate immunity, sensing
not only pathogen-associated molecular patterns but also
DAMPs (Akira et al., 2006; Lemaitre and Hoffmann, 2007).
Regarding the mechanisms underlying the immune response
triggered in the darkcd4 or WP>dark-sh flies, there are several
possibilities. It is reported that spz is mainly produced by hemo-
cytes (blood cells) and released into the hemolymph, where it is
activated (Shia et al., 2009). We speculate that in the dark
mutants, DAMPs were released into the hemolymph, where
they activated the serine protease cascade that activates spz
by proteolytic cleavage. In addition, we cannot deny the possibil-
ity that necrotic cells, rather than DAMPs, are directly sensed by
hemocytes or that some factor(s) is released under caspase-
inhibited conditions. In either case, the active form of Spz could
trigger systemic Toll activation. Recently, DAMP-mediated Toll
activation through Psh/Spz was reported in apoptosis-deficient
Drosophila larvae (Ming et al., 2014). Thus, our study suggests
the existence of endogenous DAMPs in dark mutants, although
the nature of the DAMPs and themechanism underlying Toll acti-
vation by DAMPs in Drosophila remain to be clarified.
Generating an immune response requires energy to produce a
highly inducible and coordinated set of immune-related proteins.
It is reasonable that dFoxO-dependent lipolysis is activated to
utilize lipid stores as a source of energy under an immune activa-
tion. The fat body is a central tissue for regulatingmetabolismand
innate immunity, in which both Toll and dFoxO signaling function
to maintain homeostasis. dFoxO is an evolutionally conserved
transcriptional factor that is activated during fasting and inhibits
translation through Thor/4E-BP and activates lipolysis through li-
pases. In the dark mutant, many immune-related genes were
found to be upregulated drastically in response to necrotic
WECs, leading to strong dFoxO activation and an energy-
wasting phenotype. In the adult fat body during infection, the
anabolic transcriptional regulator Mef2 changes its target from
lipogenic and glycogenic genes to genes encoding immune-
related molecules (Clark et al., 2013). However, our microarray
analysis of the dark mutant did not detect changes in anabolic
gene expression, suggesting that the TAG reduction is probably
due to enhanced lipolysis and not diminished lipogenesis.
FoxO-induced lipolysis must be tightly regulated; otherwise, a
wasting phenotype similar to that observed in Mycobacterium-
infected animals will eventually develop (Dionne et al., 2006).
Wasting is a direct cause of morbidity and mortality in some dis-
eases such as chronic inflammation or cancer (Anker et al., 2004;
Trobec et al., 2011; Fearon et al., 2012). A recent study using a
nucleotide excision repair progeria model (Ercc1/) indicated
that DNA damage signaling triggers a chronic autoinflammatory
response leading to fat depletion andwasting (Karakasilioti et al.,
2013). These mice exhibit a considerable reduction in adipocyte
size, tissue necrosis at injured sites, andmetabolic abnormalities
associated with insulin resistance, normally associated with
aging. This phenotype is reminiscent of the necrosis-induced
systemic immune response in dark mutants. Thus, the necro-
sis-driven Toll-FoxO activation observed in dark mutants may
be relevant to the pathology of age-related diseases. As reported
previously, the activation of Toll by overexpressing a constitu-
tively active form of Toll in the larval fat body (Toll10b) leads to
dFoxO activation in the same tissue (DiAngelo et al., 2009).
This crosstalk might be mediated by a reduced phospho-Akt
signal; however, our clone analysis indicated that it occurred in
a non-cell-autonomous manner. The molecular mechanisms
underlying the Toll-FoxO crosstalk are very important and need
to be clarified.
It is very important to determine whether the dFoxO-Gnmt axis
is conserved in humans and to elucidate the role that it may play
in health and disease. In mammals, Gnmt elevation was reported
in the apoE/ mouse model of atherosclerosis, in dextran so-
diumsulfate-induced colitis, and in prostate cancer tissues of hu-
man patients, although it is not known whether these inductions
were FoxO dependent (Chen et al., 2012; Chou et al., 2014; Sree-
kumar et al., 2009). FoxOactivation inducedbyattenuated insulin
signaling leads to a lifespan increase in various organisms, indi-
cating that FoxO mediates the effects of dietary restriction (DR)
(Gems and Partridge, 2013). Bioinformatic analysis has revealed
that Gnmt is one of the commonly upregulated genes induced by
‘‘longevity treatment’’ (DR and resveratrol treatment) in both the
mouse liver and the fly (Antosh et al., 2011). Considering that
both treatments lead to FoxO activation, the FoxO-Gnmt axis
that regulates SAM levels in Drosophila may be conserved and
have a role in lifespan extension. Indeed, sams knockdown
increases the lifespan in C. elegans in the same manner as DR
(Hansen et al., 2005), further supporting the notion that Gnmt
elevation/SAM reduction may positively affect longevity.
Unexpectedly, the MI was not affected, even if Gnmt was
overexpressed, indicating the existence of tight regulatory
mechanisms for Gnmt’s activity for the maintenance of MI.
Indeed, Gnmt is reported to undergo posttranslational regulation
(Luka et al., 2009). On the other hand, the darkmutant seemed to
be released from the tight regulation of MI, because an increase
in Gnmt expression in this mutant led to reductions in the SAM
level and MI, suggesting that the negative-feedback regulation
of Gnmt activity was loosened by unknown mechanisms. It is
possible that the MI is more easily affected by changes in the
gnmt level in an inflammatory state, because the Gnmt upregu-
lation by Toll activation in FB>spzact flies led to decreased
SAM levels and MI. Changes in the MI can lead to epigenetic
changes involving altered DNA or histone methylations, with crit-
ical pathological consequences under chronic inflammatory
conditions (Huynh and Casaccia, 2013; Stefanska et al., 2012;
Toubal et al., 2013; Wang et al., 2012). Thus, our findings imply
the existence of a Gnmt-mediated connection between inflam-
mation and cellular methylation status, including epigenetics.EXPERIMENTAL PROCEDURES
Drosophila Genetics and Survival Assay
Flies were maintained at 25C on a standard diet containing cornmeal, baker’s
yeast, and glucose in 60% humidity under alternating light/dark (12 hr/12 hr)conditions. After adult eclosion, flies were collected within 1 or 2 days and
maintained for 5 or 6 days with free access to food and mating and subjected
to the biochemical analysis. For the genetic manipulation in wings, we used the
GMR11F02 driver, which expresses Gal4 in the wing pouch (a part of wing
imaginal discs in the larval stage that eventually develops to adult wing) and
is designated as WP-Gal4, which was obtained from the Gal4 collection in
the Bloomington Drosophila Stock Center (Jory et al., 2012). Expression of
WP-Gal4 is restricted to wings, halteres, a part of legs, and the testis (Fig-
ure S1C). For the starvation experiment, age-matched (day 5–7) male flies
were transferred to 0.9% agar in PBS and maintained for 16 hr (darkcd4) or
24 hr (WP>dark-sh) for biochemical evaluation or until all flies had died for
the survival assay. The Kaplan-Meier log-rank test was used for the statistical
analysis of survival data using GraphPad Prism software. For clonal analysis,
target genes were overexpressed with GFP to label positive clones using the
standard flip-out technique, by crossing UAS lines to hs-flp122, UAS-mCD8-
GFP; Actin>y>Gal4, UAS-GFP. Further details are provided in Supplemental
Experimental Procedures.
Microarray and qRT-PCR Analysis
For the microarray analysis, flies were collected and total RNA was extracted
by TRIzol, followed by purification using the RNeasy Plus Micro Kit (QIAGEN).
A total of 50 ng of total RNA was subjected to analysis using the Drosophila V2
microarray, according to the manufacturer’s instructions (Agilent SureScan).
Quadruplicate samples were used for each genotype. Quantitative PCR was
performed using the Takara Premix Ex TaqII (Tli RNaseH Plus) and the Light
Cycler 480 system (Roche). Details are available in Supplemental Experimental
Procedures.
Metabolome Analysis
For the metabolome analysis by CE-MS, hemolymph from 100 day 3 adult flies
was collected as previously described (Takeishi et al., 2013), and the samples
were subjected to CE-MS for the quantification of 518 metabolites by either
positive or negative ion mode (Soga et al., 2003). For the metabolome analysis
by UPLC-MS/MS, concentration of each metabolite in the same volume of
samples extracted from 5 adult flies by 50% methanol was analyzed. UPLC-
MS/MS was performed using an UPLC system equipped with a triple quadru-
pole detector (TQD, Waters Corporation), which was established based on a
previous report (Jiang et al., 2009). Details are available in the Supplemental
Experimental Procedures.
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